Finally, a new use for temporary tattoos beyond kiddie goodie bags.
A team of Canadian researchers says it has developed a temporary “smart tattoo” to spot melanomas before they’re visible — and life-threatening.
Published last week in Nature Sensors, the new study evaluated the efficacy of SMEAR-ULM, which measures temperature variations on the skin’s surface to detect skin cancer at its earliest stages.
“Our goal is to provide a minimally invasive tool to detect very small, but still aggressive melanomas,” said senior study author Jinyang Liang.
A melanoma — also known as a “black tumor” — can appear as a new mole, a changing mole or a spot with an irregular shape, border or color, often with shades of brown, black or even pink, red or white.
Melanoma is considered the most dangerous type of skin cancer because it has a high potential to metastasize to other parts of the body if not identified and treated early.
The current protocol for diagnosing melanoma hinges on visual examinations and biopsies, the latter of which is invasive and, in some cases, unnecessary.
Researchers are hopeful that, when applied to suspicious lesions, this new technology could reduce the need for biopsies and improve diagnostic accuracy.
“Because of their small size, the melanomas are usually excluded from clinical visual inspection, which leaves the threat unwatched. We want to detect them so that intervention can be made as soon as possible,” said Liang.
The temporary patch contains pain-free microneedles that deposit nanoparticles beneath the skin that function as microscopic thermometers.
When exposed to near-infrared light, the nanoparticles emit visible light that depends on local temperature.
Researchers note that cancer cells consume more oxygen and emit more heat than healthy cells, a temperature difference that the patch can detect and visually signal.
Researchers shared that the patch establishes skin temperature as a precise diagnostic biomarker for early-stage melanoma.
“We capture all the necessary information for an instantaneous temperature map in a single shot, which makes the method fast and robust to continuously monitor abnormal thermal responses in small melanomas,” said first author Yingming Lai.
The team tested the technology on mice and successfully detected micro‑melanomas as young as 4 days old, a stage at which melanomas are too small to be detected via conventional imaging techniques.
A breakthrough like this could not come soon enough.
The Skin Cancer Foundation predicts that 234,680 cases of melanoma will be diagnosed in the US in 2026, a staggering 10.6% increase from 2025.
Of these projected cases, 122,680 will be noninvasive, or confined to the top layer of skin, while 112,000 cases will be invasive, penetrating the epidermis into the skin’s second layer.
In noninvasive cases where melanoma hasn’t spread beyond the skin, 99 out of 100 patients will survive for five years after diagnosis, according to the American Cancer Society.
That number drops significantly, to just 35 out of 100 patients, when the cancer has spread to distant parts of the body, like the lungs or liver.
Unfortunately, these latest figures align with a troubling trend. In the past decade, the number of new invasive melanoma cases diagnosed annually increased by 46.6%.
Things to look for are the “ABCDEs” of melanoma — asymmetry, border irregularity, color variability, diameter greater than 6 millimeters, roughly the size of a pencil eraser.
The risk of melanoma also increases with age. The average age of Americans diagnosed is 66, but it’s one of the most common cancers in people under 30 — especially young women.
Other risk factors include being male, having several moles, a personal or family history of the disease and a history of blistering sunburns, particularly in childhood. People who spend a lot of time outdoors may also face a higher risk due to increased sun exposure.
